Peer Review reports
From: Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
| Original Submission | ||
|---|---|---|
| 1 Nov 2007 | Submitted | Original manuscript |
| 29 Nov 2007 | Reviewed | Reviewer Report - Alexander Dobrovic |
| 7 Jan 2008 | Reviewed | Reviewer Report - Qian Tao |
| 22 Jan 2008 | Author responded | Author comments - Richard L Momparler |
| Resubmission - Version 2 | ||
| 22 Jan 2008 | Submitted | Manuscript version 2 |
| 11 Feb 2008 | Reviewed | Reviewer Report - Alexander Dobrovic |
| 11 Feb 2008 | Reviewed | Reviewer Report - Qian Tao |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 1 May 2008 | Author responded | Author comments - Richard L Momparler |
| Resubmission - Version 4 | ||
| 1 May 2008 | Submitted | Manuscript version 4 |
| Publishing | ||
| 2 May 2008 | Editorially accepted | |
| 2 May 2008 | Article published | 10.1186/1471-2407-8-128 |
You can find further information about peer review here.